Search
for

    Sort by

    Research 211–240 of 1000+

    1. Novel inhibitors of 5α-reductase Expert Opinion on Therapeutic Patents · 2002 · 20 citations
    2. Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase Tetrahedron Letters · 1995 · 20 citations
    3. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    4. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    5. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor Bioorganic & Medicinal Chemistry Letters · 2010 · 18 citations
    6. A regulatory perspective on pharmacokinetic/pharmacodynamic modelling Statistical Methods in Medical Research · 1999 · 18 citations
    7. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm The World Journal of Men's Health · 2020 · 17 citations
    8. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    9. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    10. A preliminary study on the relationship between environmental endocrine disruptors and precocious puberty in girls Journal of Pediatric Endocrinology and Metabolism · 2022 · 16 citations
    11. Safety aspects of androgen treatment with 5α-dihydrotestosterone Andrologia · 2007 · 16 citations
    12. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    13. The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men Food Reviews International · 2018 · 15 citations
    14. 5α-Reductase Inhibitors (5ARIs) and Male Reproduction Advances in Experimental Medicine and Biology · 2017 · 15 citations
    15. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    16. Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris Dermatologic Clinics · 2016 · 15 citations
    17. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    18. α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model Molecular Medicine Reports · 2014 · 15 citations
    19. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature Archivio Italiano di Urologia e Andrologia · 2020 · 14 citations
    20. Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia Therapeutic advances in urology · 2016 · 14 citations
    21. Oral administration of low-dose bisphenol A promotes proliferation of ventral prostate and upregulates prostaglandin D<sub>2</sub> synthase expression in adult rats Toxicology and Industrial Health · 2015 · 14 citations
    22. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors Steroids · 2011 · 14 citations
    23. Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions Bioorganic & Medicinal Chemistry Letters · 1998 · 14 citations
    24. Finasteride Induced Gynecomastia The Journal of Urology · 1997 · 14 citations
    25. Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist Tetrahedron Letters · 1994 · 14 citations
    26. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study Urologic Oncology: Seminars and Original Investigations · 2018 · 13 citations
    27. Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids Steroids · 2015 · 13 citations
    28. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    29. Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men Steroids · 1997 · 13 citations
    30. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? Medical hypotheses · 2020 · 12 citations